505 related articles for article (PubMed ID: 26523731)
1. Association of Off-label Drug Use and Adverse Drug Events in an Adult Population.
Eguale T; Buckeridge DL; Verma A; Winslade NE; Benedetti A; Hanley JA; Tamblyn R
JAMA Intern Med; 2016 Jan; 176(1):55-63. PubMed ID: 26523731
[TBL] [Abstract][Full Text] [Related]
2. Drug, patient, and physician characteristics associated with off-label prescribing in primary care.
Eguale T; Buckeridge DL; Winslade NE; Benedetti A; Hanley JA; Tamblyn R
Arch Intern Med; 2012 May; 172(10):781-8. PubMed ID: 22507695
[TBL] [Abstract][Full Text] [Related]
3. Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.
Wong J; Motulsky A; Abrahamowicz M; Eguale T; Buckeridge DL; Tamblyn R
BMJ; 2017 Feb; 356():j603. PubMed ID: 28228380
[No Abstract] [Full Text] [Related]
4. Risk factors for hospital admissions associated with adverse drug events.
Kongkaew C; Hann M; Mandal J; Williams SD; Metcalfe D; Noyce PR; Ashcroft DM
Pharmacotherapy; 2013 Aug; 33(8):827-37. PubMed ID: 23686895
[TBL] [Abstract][Full Text] [Related]
5. Incidence and predictors of major adverse drug events among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara regional state public hospitals; Ethiopia: a retrospective cohort study.
Merid MW; Gezie LD; Kassa GM; Muluneh AG; Akalu TY; Yenit MK
BMC Infect Dis; 2019 Mar; 19(1):286. PubMed ID: 30917788
[TBL] [Abstract][Full Text] [Related]
6. Adverse drug events identified by triggers at a teaching hospital in Brazil.
Giordani F; Rozenfeld S; Martins M
BMC Pharmacol Toxicol; 2014 Dec; 15():71. PubMed ID: 25496209
[TBL] [Abstract][Full Text] [Related]
7. Causality and preventability assessment of adverse drug reactions and adverse drug events of antibiotics among hospitalized patients: A multicenter, cross-sectional study in Lahore, Pakistan.
Iftikhar S; Sarwar MR; Saqib A; Sarfraz M
PLoS One; 2018; 13(6):e0199456. PubMed ID: 29949616
[TBL] [Abstract][Full Text] [Related]
8. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care.
Thomsen LA; Winterstein AG; Søndergaard B; Haugbølle LS; Melander A
Ann Pharmacother; 2007 Sep; 41(9):1411-26. PubMed ID: 17666582
[TBL] [Abstract][Full Text] [Related]
9. Incidence of adverse drug events in an academic hospital: a prospective cohort study.
Aljadhey H; Mahmoud MA; Mayet A; Alshaikh M; Ahmed Y; Murray MD; Bates DW
Int J Qual Health Care; 2013 Dec; 25(6):648-55. PubMed ID: 24141014
[TBL] [Abstract][Full Text] [Related]
10. A Multicenter Evaluation of Off-Label Medication Use and Associated Adverse Drug Reactions in Adult Medical ICUs.
Smithburger PL; Buckley MS; Culver MA; Sokol S; Lat I; Handler SM; Kirisci L; Kane-Gill SL
Crit Care Med; 2015 Aug; 43(8):1612-21. PubMed ID: 25855897
[TBL] [Abstract][Full Text] [Related]
11. Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.
Moisan J; Grégoire JP
Clin Ther; 2010; 32 Suppl 1():S21-31. PubMed ID: 20152549
[TBL] [Abstract][Full Text] [Related]
12. Hospital admissions caused by adverse drug events: an Australian prospective study.
Phillips AL; Nigro O; Macolino KA; Scarborough KC; Doecke CJ; Angley MT; Shakib S
Aust Health Rev; 2014 Feb; 38(1):51-7. PubMed ID: 24351707
[TBL] [Abstract][Full Text] [Related]
13. Is off-label use a risk factor for adverse drug reactions in pediatric patients? A prospective study in an Indian tertiary care hospital.
Saiyed MM; Lalwani T; Rana D
Int J Risk Saf Med; 2015; 27(1):45-53. PubMed ID: 25766066
[TBL] [Abstract][Full Text] [Related]
14. Off-label prescribing in pediatric outpatients.
Palmaro A; Bissuel R; Renaud N; Durrieu G; Escourrou B; Oustric S; Montastruc JL; Lapeyre-Mestre M
Pediatrics; 2015 Jan; 135(1):49-58. PubMed ID: 25511119
[TBL] [Abstract][Full Text] [Related]
15. Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study.
Pratico AD; Longo L; Mansueto S; Gozzo L; Barberi I; Tiralongo V; Salvo V; Falsaperla R; Vitaliti G; La Rosa M; Leonardi S; Rotondo A; Avola N; Sgarlata D; Damiano A; Tirantello M; Anzelmo G; Cipolla D; Rizzo A; Russo A; Ruggieri M; Salomone S; Drago F
Curr Drug Saf; 2018; 13(3):200-207. PubMed ID: 29921210
[TBL] [Abstract][Full Text] [Related]
16. Association of Opioid Consumption Profiles After Hospitalization With Risk of Adverse Health Care Events.
Kurteva S; Abrahamowicz M; Gomes T; Tamblyn R
JAMA Netw Open; 2021 May; 4(5):e218782. PubMed ID: 34003273
[TBL] [Abstract][Full Text] [Related]
17. Patterns and predictors of off-label prescription of psychiatric drugs.
Vijay A; Becker JE; Ross JS
PLoS One; 2018; 13(7):e0198363. PubMed ID: 30024873
[TBL] [Abstract][Full Text] [Related]
18. Use of off-label nephrology-related drugs in hospitalized pediatric patients: a retrospective study.
Yasinta M; Che RC; Hu CY; Du XH; Ding GX; Huang SM; Chen Y; Zhang AH
World J Pediatr; 2016 May; 12(2):236-42. PubMed ID: 26684307
[TBL] [Abstract][Full Text] [Related]
19. Ambulatory Computerized Prescribing and Preventable Adverse Drug Events.
Overhage JM; Gandhi TK; Hope C; Seger AC; Murray MD; Orav EJ; Bates DW
J Patient Saf; 2016 Jun; 12(2):69-74. PubMed ID: 26001546
[TBL] [Abstract][Full Text] [Related]
20. Adverse drug event nonrecognition in emergency departments: an exploratory study on factors related to patients and drugs.
Roulet L; Ballereau F; Hardouin JB; Chiffoleau A; Potel G; Asseray N
J Emerg Med; 2014 Jun; 46(6):857-64. PubMed ID: 24565882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
